Proposed Data Collection Submitted for Public Comment and Recommendations, 90701-90703 [2024-26778]
Download as PDF
<![CDATA[
90701
Federal Register / Vol. 89, No. 222 / Monday, November 18, 2024 / Notices
information that will be collected will
also strengthen CDC’s ability to monitor
grantee progress towards stated grant
research, training, and outreach
objectives, provide data-driven
technical assistance, and disseminate
Success Stories about what is working
to reduce unintentional and intentional
injuries.
To improve and innovate through
evaluation, research, and quality
improvement; investigate, diagnose, and
address health hazards and root causes;
communicate effectively to inform and
educate; strengthen, support, and
mobilize communities and partnerships;
and create, champion, and implement
policies, plans, and laws are five of the
noted public health activities that all
public health systems should undertake.
CDC ICRC grantees do all of these
activities, and the systematic collection
of data, annually, is the best way for
CDC to understand this work. This APR
information collection will enable
grantees to submit accurate, reliable,
and timely activity and performance
data to the CDC.
CDC requests OMB approval for an
estimated 231 annual burden hours.
There is no cost to respondents other
than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Injury Research Center (ICRC) Grantees ......
ICRC Indicators Data Collection Annual
Progress Report.
Publication Table ............................................
Success Stories Template .............................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–26779 Filed 11–15–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-25–0728; Docket No. CDC–2024–
0095]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled National
Notifiable Diseases Surveillance System.
This data collection provides the official
source of statistics in the United States
for nationally notifiable conditions.
DATES: CDC must receive written
comments on or before January 17,
2025.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondents
VerDate Sep<11>2014
17:17 Nov 15, 2024
Jkt 265001
You may submit comments,
identified by Docket No. CDC–2024–
0095 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road, NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
ADDRESSES:
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
11
1
8
11
11
1
5
8
1
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
National Notifiable Diseases
Surveillance System (NNDSS) (OMB
Control No. 0920–0728, Exp. 3/31/
2027)—Revision—Office of Public
Health Data, Surveillance, and
Technology (OPHDST), Centers for
Disease Control and Prevention (CDC).
E:\FR\FM\18NON1.SGM
18NON1
90702
Federal Register / Vol. 89, No. 222 / Monday, November 18, 2024 / Notices
Background and Brief Description
The Public Health Services Act (42
U.S.C. 241) authorizes CDC to
disseminate nationally notifiable
condition information. The National
Notifiable Diseases Surveillance System
(NNDSS) is based on data collected at
the state, territorial and local levels
because of legislation and regulations in
those jurisdictions that require health
care providers, medical laboratories,
and other entities to submit healthrelated data on reportable conditions to
public health departments. These
reportable conditions, which include
infectious and non-infectious diseases,
vary by jurisdiction depending upon
each jurisdiction’s health priorities and
needs. Each year, the Council of State
and Territorial Epidemiologists (CSTE),
supported by CDC, determines which
reportable conditions should be
designated nationally notifiable or
under standardized surveillance.
CDC requests a three-year approval for
a Revision for the NNDSS (OMB Control
No. 0920–0728, Exp. 03/31/2027). This
Revision includes requests for approval
to: 1) receive case notification data for
Cronobacter and Ehrlichiosis, new
notifiable conditions; 2) receive case
notification data for Congenital
cytomegalovirus infection and
Toxoplasmosis, new conditions under
standardized surveillance; and 3)
receive new disease-specific data
elements for Cronobacter, Hansen’s
Disease (Leprosy,) and Leptospirosis.
The NNDSS currently facilitates the
submission and aggregation of case
notification data voluntarily submitted
to CDC from 60 jurisdictions: public
health departments in every U.S. state,
of Standards and Technology (NIST)
Recommended Security Controls for
Federal Information Systems and
Organizations. Weekly tables of
nationally notifiable diseases are
available through CDC WONDER and
data.cdc.gov. Annual summaries of
finalized nationally notifiable disease
data are published on CDC WONDER
and data.cdc.gov and disease-specific
data are published by individual CDC
programs.
The burden estimates include the
number of hours that the public health
department uses to process and send
case notification data from their
jurisdiction to CDC. Specifically, the
burden estimates include separate
burden hours incurred for automated
and non-automated transmissions,
separate weekly burden hours incurred
for modernizing surveillance systems as
part of CDC’s Data Modernization
Initiative (DMI) implementation,
separate burden hours incurred for
annual data reconciliation and
submission, and separate one-time
burden hours incurred for the addition
of new diseases and data elements. The
burden estimates for the one-time
burden for reporting jurisdictions are for
the addition of case notification data for
Cronobacter and Ehrlichiosis, new
notifiable conditions; the addition of
case notification data for Congenital
cytomegalovirus infection and
Toxoplasmosis, new conditions under
standardized surveillance; and the
addition of new disease-specific data
elements for Cronobacter, Hansen’s
Disease (Leprosy) and Leptospirosis.
CDC requests OMB approval for an
estimated 18,414 annual burden hours.
New York City, Washington DC, five
U.S. territories (American Samoa, the
Commonwealth of Northern Mariana
Islands, Guam, Puerto Rico, and the U.S.
Virgin Islands), and three freely
associated states (Federated States of
Micronesia, the Republic of the
Marshall Islands, and the Republic of
Palau). This information is shared
across jurisdictional boundaries and
both surveillance and prevention and
control activities are coordinated at
regional and national levels.
Approximately 90% of case
notifications are encrypted and
submitted to NNDSS electronically from
already existing databases by automated
electronic messages. When automated
transmission is not possible, case
notifications are faxed, emailed,
uploaded to a secure network or entered
into a secure website. All case
notifications that are faxed or emailed
are done so in the form of an aggregate
weekly or annual report, not individual
cases. These different mechanisms used
to send case notifications to CDC vary
by the jurisdiction and the disease or
condition. Jurisdictions remove most
personally identifiable information (PII)
before data are submitted to CDC, but
some data elements (e.g., date of birth,
date of diagnosis, county of residence)
could potentially be combined with
other information to identify
individuals. Private information is not
disclosed unless otherwise compelled
by law. All data are treated in a secure
manner consistent with the technical,
administrative, and operational controls
required by the Federal Information
Security Management Act of 2002
(FISMA) and the 2010 National Institute
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
States
States
States
States
States
......................................................
......................................................
......................................................
......................................................
......................................................
lotter on DSK11XQN23PROD with NOTICES1
Territories
Territories
Territories
Territories
Territories
Freely
Freely
Freely
Freely
Form name
................................................
................................................
................................................
................................................
................................................
Associated
Associated
Associated
Associated
States
States
States
States
........................
........................
........................
........................
Cities .......................................................
Cities .......................................................
Cities .......................................................
VerDate Sep<11>2014
17:17 Nov 15, 2024
Jkt 265001
Weekly (Automated) ...............................
Weekly (Non- automated) ......................
Weekly (DMI Implementation) ................
Annual .....................................................
One-time Addition of Diseases and Data
Elements.
Weekly (Automated) ...............................
Weekly, Quarterly (Non-automated) .......
Weekly (DMI Implementation) ................
Annual .....................................................
One-time Addition of Diseases and Data
Elements.
Weekly (Automated) ...............................
Weekly, Quarterly (Non-automated) .......
Annual .....................................................
One-time Addition of Diseases and Data
Elements.
Weekly (Automated) ...............................
Weekly (Non-automated) ........................
Weekly (DMI Implementation) ................
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Average
burden per
response
(in hours)
Number of
respondents
Number of
responses per
respondent
50
10
50
50
50
52
52
52
1
1
20/60
2
4
75
3
867
1,040
10,400
3,750
150
5
5
5
5
5
52
56
52
1
1
20/60
20/60
4
5
3
87
93
1,040
25
15
3
3
3
3
52
56
1
1
20/60
20/60
5
3
52
56
15
9
2
2
2
52
52
52
20/60
2
4
35
208
416
E:\FR\FM\18NON1.SGM
18NON1
Total
burden
(in hours)
90703
Federal Register / Vol. 89, No. 222 / Monday, November 18, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
responses per
respondent
Annual .....................................................
One-time Addition of Diseases and Data
Elements.
2
2
1
1
75
3
150
6
.................................................................
....................
........................
....................
18,414
Form name
Cities .......................................................
Cities .......................................................
Total .................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–26778 Filed 11–15–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–25–24HQ]
lotter on DSK11XQN23PROD with NOTICES1
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Division of
Diabetes Translation Programmatic &
Participant User Experience Data
Collection (DDTDC)’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on July 26,
2024 to obtain comments from the
public and affected agencies. CDC
received zero comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
VerDate Sep<11>2014
17:17 Nov 15, 2024
Jkt 265001
Average
burden per
response
(in hours)
Number of
respondents
Type of respondent
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Division of Diabetes Translation
Programmatic & Participant User
Experience Data Collection (DDTDC)—
New—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Division of Diabetes Translation
(DDT) plays a crucial role in helping
prevent Type 2 diabetes, reducing
diabetes complications and disability,
and reducing diabetes-related
disparities across the United States.
DDT accomplishes this by providing
education, training, technical assistance
(TA), and engaging in communication/
marketing activities for various key
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Total
burden
(in hours)
audiences. These customers include
national, state, and local partners,
grantees, providers (e.g., lifestyle
coaches, diabetes educators, healthcare
providers, health/medical and
community-based organizations), people
with prediabetes, diabetes and their
family, friends, and caregivers, and
other consumers of DDT products and
programs.
For DDT to be able to efficiently and
effectively do this work and fulfill its
mission, it needs to be able to collect
information and feedback from intended
audiences in a timely manner and with
enough frequency to ensure DDT can
deliver clear, effective, efficient, and
appropriate customer service. This
includes, for instance, collecting data on
key audiences’ needs and on the reach,
uptake, use, customer experience and
satisfaction with DDT’s services,
products, and related programs,
including its education, training, TA
and communications services and
products.
However, in the interest of timely
provision of services, DDT often forgoes
the important step of getting input from
its key audiences on the clarity,
efficiency, effectiveness, and
appropriateness of the services and
resources it develops and provides for
them. Skipping this information
collection step, or doing so with less
frequency, avoids the delay involved in
the standard OMB review process, but
increases the risk of DDT wasting both
time and money developing and
providing education, training, TA, and
communication/marketing that will not
achieve the intended objectives and will
be unclear, irrelevant, or not fully meet
the needs of DDT’s audiences. It can
also have other unintended
consequences, such as jeopardizing the
credibility of Federal health officials.
The Division of Diabetes Translation
Programmatic & Participant User
Experience Data Collection (DDTDC)
will enable DDT to collect the
information they require in a timely
manner to:
• Provide clear, effective, efficient,
appropriate, and timely education,
communication, training, and technical
E:\FR\FM\18NON1.SGM
18NON1
]]>Agencies
[Federal Register Volume 89, Number 222 (Monday, November 18, 2024)]
[Notices]
[Pages 90701-90703]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-26778]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-25-0728; Docket No. CDC-2024-0095]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled National Notifiable Diseases Surveillance System. This data
collection provides the official source of statistics in the United
States for nationally notifiable conditions.
DATES: CDC must receive written comments on or before January 17, 2025.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0095 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road,
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
National Notifiable Diseases Surveillance System (NNDSS) (OMB
Control No. 0920-0728, Exp. 3/31/2027)--Revision--Office of Public
Health Data, Surveillance, and Technology (OPHDST), Centers for Disease
Control and Prevention (CDC).
[[Page 90702]]
Background and Brief Description
The Public Health Services Act (42 U.S.C. 241) authorizes CDC to
disseminate nationally notifiable condition information. The National
Notifiable Diseases Surveillance System (NNDSS) is based on data
collected at the state, territorial and local levels because of
legislation and regulations in those jurisdictions that require health
care providers, medical laboratories, and other entities to submit
health-related data on reportable conditions to public health
departments. These reportable conditions, which include infectious and
non-infectious diseases, vary by jurisdiction depending upon each
jurisdiction's health priorities and needs. Each year, the Council of
State and Territorial Epidemiologists (CSTE), supported by CDC,
determines which reportable conditions should be designated nationally
notifiable or under standardized surveillance.
CDC requests a three-year approval for a Revision for the NNDSS
(OMB Control No. 0920-0728, Exp. 03/31/2027). This Revision includes
requests for approval to: 1) receive case notification data for
Cronobacter and Ehrlichiosis, new notifiable conditions; 2) receive
case notification data for Congenital cytomegalovirus infection and
Toxoplasmosis, new conditions under standardized surveillance; and 3)
receive new disease-specific data elements for Cronobacter, Hansen's
Disease (Leprosy,) and Leptospirosis.
The NNDSS currently facilitates the submission and aggregation of
case notification data voluntarily submitted to CDC from 60
jurisdictions: public health departments in every U.S. state, New York
City, Washington DC, five U.S. territories (American Samoa, the
Commonwealth of Northern Mariana Islands, Guam, Puerto Rico, and the
U.S. Virgin Islands), and three freely associated states (Federated
States of Micronesia, the Republic of the Marshall Islands, and the
Republic of Palau). This information is shared across jurisdictional
boundaries and both surveillance and prevention and control activities
are coordinated at regional and national levels.
Approximately 90% of case notifications are encrypted and submitted
to NNDSS electronically from already existing databases by automated
electronic messages. When automated transmission is not possible, case
notifications are faxed, emailed, uploaded to a secure network or
entered into a secure website. All case notifications that are faxed or
emailed are done so in the form of an aggregate weekly or annual
report, not individual cases. These different mechanisms used to send
case notifications to CDC vary by the jurisdiction and the disease or
condition. Jurisdictions remove most personally identifiable
information (PII) before data are submitted to CDC, but some data
elements (e.g., date of birth, date of diagnosis, county of residence)
could potentially be combined with other information to identify
individuals. Private information is not disclosed unless otherwise
compelled by law. All data are treated in a secure manner consistent
with the technical, administrative, and operational controls required
by the Federal Information Security Management Act of 2002 (FISMA) and
the 2010 National Institute of Standards and Technology (NIST)
Recommended Security Controls for Federal Information Systems and
Organizations. Weekly tables of nationally notifiable diseases are
available through CDC WONDER and data.cdc.gov. Annual summaries of
finalized nationally notifiable disease data are published on CDC
WONDER and data.cdc.gov and disease-specific data are published by
individual CDC programs.
The burden estimates include the number of hours that the public
health department uses to process and send case notification data from
their jurisdiction to CDC. Specifically, the burden estimates include
separate burden hours incurred for automated and non-automated
transmissions, separate weekly burden hours incurred for modernizing
surveillance systems as part of CDC's Data Modernization Initiative
(DMI) implementation, separate burden hours incurred for annual data
reconciliation and submission, and separate one-time burden hours
incurred for the addition of new diseases and data elements. The burden
estimates for the one-time burden for reporting jurisdictions are for
the addition of case notification data for Cronobacter and
Ehrlichiosis, new notifiable conditions; the addition of case
notification data for Congenital cytomegalovirus infection and
Toxoplasmosis, new conditions under standardized surveillance; and the
addition of new disease-specific data elements for Cronobacter,
Hansen's Disease (Leprosy) and Leptospirosis. CDC requests OMB approval
for an estimated 18,414 annual burden hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total
Type of respondent Form name respondents responses per response burden (in
respondent (in hours) hours)
----------------------------------------------------------------------------------------------------------------
States............................ Weekly (Automated)... 50 52 20/60 867
States............................ Weekly (Non- 10 52 2 1,040
automated).
States............................ Weekly (DMI 50 52 4 10,400
Implementation).
States............................ Annual............... 50 1 75 3,750
States............................ One-time Addition of 50 1 3 150
Diseases and Data
Elements.
Territories....................... Weekly (Automated)... 5 52 20/60 87
Territories....................... Weekly, Quarterly 5 56 20/60 93
(Non-automated).
Territories....................... Weekly (DMI 5 52 4 1,040
Implementation).
Territories....................... Annual............... 5 1 5 25
Territories....................... One-time Addition of 5 1 3 15
Diseases and Data
Elements.
Freely Associated States.......... Weekly (Automated)... 3 52 20/60 52
Freely Associated States.......... Weekly, Quarterly 3 56 20/60 56
(Non-automated).
Freely Associated States.......... Annual............... 3 1 5 15
Freely Associated States.......... One-time Addition of 3 1 3 9
Diseases and Data
Elements.
Cities............................ Weekly (Automated)... 2 52 20/60 35
Cities............................ Weekly (Non- 2 52 2 208
automated).
Cities............................ Weekly (DMI 2 52 4 416
Implementation).
[[Page 90703]]
Cities............................ Annual............... 2 1 75 150
Cities............................ One-time Addition of 2 1 3 6
Diseases and Data
Elements.
-----------------------------------------------------------------------------
Total......................... ..................... ........... .............. ........... 18,414
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-26778 Filed 11-15-24; 8:45 am]
BILLING CODE 4163-18-P
